statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its...

Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today...

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc. (NYSE:RCUS - Get Free Report)'s stock price fell 2.8% during mid-day trading on Wednesday . The company traded as low as $17.14 and last traded at $17.23. 14,247 shares...

Arcus Biosciences (NYSE:RCUS)  Shares Down 2.8%

This is a signal that RCUS's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Arcus Biosciences (RCUS, $18.48) Stochastic Oscillator left the overbought zone on April 01, 2024

This indicator may be signaling that RCUS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Arcus Biosciences (RCUS, $18.48) entered Downtrend as Momentum indicator drops below 0 level on Apr 01, 2024

This is a Bullish indicator signaling RCUS's price could rise from here. Traders may explore going long the stock or buying call options...

Arcus Biosciences (RCUS, $18.48) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 1, 2024

Insider Sell: COO Jennifer Jarrett Sells 11,551 Shares of Arcus Biosciences Inc (RCUS)

This price move could indicate a change in the trend, and may be a buy signal for investors...

Arcus Biosciences (RCUS, $18.21) price moved above its 50-day Moving Average on March 27, 2024

This is a signal that RCUS's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Arcus Biosciences (RCUS, $18.21) Stochastic Oscillator left the oversold zone on March 27, 2024

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Watchers	1,409
52-Wk Low	$12.95
52-Wk High	$25.47

Volume	302,687.00
52-Wk High	$25.47
52-Wk Low	$12.95

RCUS Arcus Biosciences Inc

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community